CarlJoshuaDanzigMD

Ophthalmology • Deerfield Beach, FL

Retinal Disease

Physician

Join to view full profile

Dr. Danzig is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Danzig's full profile

Already have an account?

Office
5 west sample Rd
Deerfield Beach, FL 33064
Phone+1 954-782-1700

Fax+1 954-782-7490

Education & Training

SUNY Downstate Health Sciences UniversityResidency, Ophthalmology, 2007 - 2009
Crozer-Chester Medical CenterInternship, Transitional Year, 2004 - 2005
Lewis Katz School of Medicine at Temple UniversityClass of 2004

Certifications & Licensure

CA State Medical License 2006 - 2025
FL State Medical License 2011 - 2025
TX State Medical License 2009 - 2025
PA State Medical License 2004 - 2005
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Compulink Advantage EHR, Compulink, 2012-2014

Publications & Presentations

PubMed

Patient Preferences with Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema: A Multinational...
Alfredo García-Layana, Gloria C Chi, Laurent Kodjikian, Mariacristina Parravano, David Chow
Ophthalmic Research. 2025-01-01
3 citations
Vision Loss Reduction with Avacincaptad Pegol for Geographic Atrophy: A 12-Month Post Hoc Analysis of the GATHER1 and GATHER2 Trials.
Carl J Danzig, Arshad M Khanani, Peter K Kaiser, Margaret A Chang, Jaclyn L Kovach
Ophthalmology. Retina. 2024-11-01
1 citations
Screen Failures in Clinical Trials in Retina.
Nasiq Hasan, Kunaal Mehrotra, Carl J Danzig, David A Eichenbaum, Amy Ewald
Ophthalmology. Retina. 2024-11-01

Authored Content

Faricimab Appears Comparable to Ranibizumab Through 52 WeeksOctober 2020
Risk Factors for Poor Outcomes After Vitrectomy for Macular HoleDecember 2018
Risk Factors for Poor Outcomes After Vitrectomy for Macular HoleDecember 2018
Does ILM Peeling Improve Outcomes in Epiretinal Membrane Surgery?June 2018
Join now to see all

Press Mentions

Oculis Accelerates Enrollment for Phase 3 DIAMOND Trials of OCS-01 Eye Drops in DMEOctober 21st, 2024
Results from the Phase 3 BALATON and COMINO Studies at 72 WeeksJuly 18th, 2024
Medical Spa Marianna, FlJanuary 14th, 2019